Document:

<PAGE>

                                                                    Exhibit 10.9

                                 AMERISAFE, INC.

                2005 NON-EMPLOYEE DIRECTOR RESTRICTED STOCK PLAN

1.          PURPOSE. The purpose of this 2005 Non-Employee Director Restricted
      Stock Plan is to attract and retain qualified individuals who are not
      employed by the Company to serve as Directors.

2.          DEFINITIONS. As used in this Plan,

      (a)         "Annual Grant" means a grant of Restricted Stock to a
            Non-Employee Director in accordance with Section 5 of this Plan.

      (b)         "Annual Meeting" means the Company's annual meeting of
            shareholders.

      (c)         "Award" means any award of an Initial Grant or Annual Grant
            under this Plan.

      (d)         "Award Agreement" means a written agreement between the
            Company and a Non-Employee Director setting forth the terms,
            conditions and restrictions of the Award granted to the Non-Employee
            Director.

      (e)         "Board" means the Board of Directors of the Company.

      (f)         "Change in Control" shall have the meaning provided in
            Section 6 of this Plan.

      (g)         "Common Shares" means the shares of common stock, par value
            $0.01 per share, of the Company or any security into which such
            Common Shares may be changed by reason of any transaction or event
            of the type referred to in Section 3(b) of this Plan.

      (h)         "Company" means AMERISAFE, Inc., a Texas corporation.

      (i)         "Date of Grant" means (i) with respect to an Initial Grant,
            the close of business on the date on which the Non-Employee
            Director is first elected or appointed to the Board, and (ii)
            with respect to an Annual Grant, the date on which the Annual
            Meeting in any calendar year is first convened.

      (j)         "Director" means a member of the Board.

      (k)         "Effective Date" means __________, 2005.

      (l)         "Exchange Act" means the Securities Exchange Act of 1934, as
            amended, and the rules and regulations thereunder, as such law,
            rules and regulations may be amended from time to time.

<PAGE>

      (m)         "Incumbent Directors" means the individuals who, as of the
            Effective Date, are Directors of the Company and any individual
            becoming a Director subsequent to the date thereof whose election,
            nomination for election by the Company's shareholders, or
            appointment, was approved by a vote of at least two-thirds of the
            then Incumbent Directors (either by a specific vote or by approval
            of the proxy statement of the Company in which such person is named
            as a nominee for Director, without objection to such nomination);
            provided, however, that an individual shall not be an Incumbent
            Director if such individual's election or appointment to the Board
            occurs as a result of an actual or threatened election contest (as
            described in Rule 14a-12(c) of the Exchange Act) with respect to the
            election or removal of Directors or other actual or threatened
            solicitation of proxies or consents by or on behalf of a Person
            other than the Board.

      (n)         "Initial Grant" means a grant of shares of Restricted Stock to
            a Non-Employee Director in accordance with Section 4 of this Plan.

      (o)         "Market Value per Share" means, as of any particular date, (i)
            the closing sale price per Common Share on that date (or if there
            are no sales on that date, on the next preceding trading date during
            which a sale occurred) as reported on the Nasdaq National Market
            System, or if the Common Shares are not then-traded on the Nasdaq
            National Market System, the principal exchange on which the Common
            Shares are then trading, or (ii) if clause (i) does not apply, the
            fair value of the Common Shares as determined by the Board.

      (p)         "Non-Employee Director" means each member of the Board from
            time to time who is not an employee of the Company or any of its
            Affiliates.

      (q)         "Person" means any individual, entity or group (within the
            meaning of Section 13(d)(3) or 14(d)(2) of the Exchange Act).

      (r)         "Plan" means this 2005 Non-Employee Director Plan.

      (s)         "Restricted Stock" means Common Shares as to which neither the
            substantial risk of forfeiture nor the prohibition on transfers
            referred to in Section 4 or Section 5 of this Plan has lapsed.

      (t)         "Subsidiary" means a corporation, company or other entity (i)
            more than 50 percent of whose outstanding shares or other securities
            (representing the right to vote for the election of directors or
            other managing authority) are, or (ii) which does not have
            outstanding shares or other securities (as may be the case in a
            partnership, limited liability company, business trust or other
            legal entity), but more than 50 percent of whose ownership interest
            representing the right generally to make decisions for such entity
            is, now or hereafter, owned or controlled, directly or indirectly,
            by the Company.

      (u)         "Total Disability" means the permanent or total disability of
            a Non-Employee Director, as determined by the Board in good faith.

                                       2
<PAGE>

      (v)         "Voting Securities" means, at any time, (i) the securities
            entitled to vote generally in the election of Directors in the case
            of the Company, or (ii) the securities entitled to vote generally in
            the election of members of the board of directors or similar body in
            the case of another legal entity.

3.          SHARES AVAILABLE UNDER THE PLAN.

      (a)         Subject to adjustment as provided in Section 3(b) of this
            Plan, the number of Common Shares that may be issued or transferred
            as Restricted Stock and released from substantial risk of forfeiture
            thereof shall not exceed in the aggregate ______ Common Shares. Such
            shares may be authorized but unissued shares or treasury shares or a
            combination of the foregoing.

      (b)         The number of shares available in Section 3(a) above shall be
            adjusted to account for shares relating to Awards that are
            forfeited. The number and type of shares available in Section 3(a)
            shall also automatically be adjusted to reflect (a) any stock split,
            combination of shares, recapitalization or other change in the
            capital structure of the Company, (b) any merger, consolidation,
            spin-off, split-off, spin-out, split-up, reorganization, partial or
            complete liquidation or other distribution of assets, issuance of
            rights or warrants to purchase securities, or (c) any other
            corporate transaction or event having an effect similar to any of
            the foregoing.

4.          INITIAL GRANTS

      (a)         Without any further action of the Board, each person who is
            elected or appointed for the first time to be a Non-Employee
            Director shall automatically receive an Initial Grant determined by
            dividing $_______ (prorated as determined below in this Section
            4(a)) by the Market Value per Share on the Date of Grant; provided,
            however, that the number of shares of Restricted Stock shall be
            rounded downward such that no fractional share shall be issued. If
            any such person is so elected or appointed other than at an Annual
            Meeting, the Initial Grant shall be prorated for the number of whole
            months that such Non-Employee Director will serve until the first
            anniversary of the immediately preceding Annual Meeting.

      (b)         In lieu of the Initial Grant contemplated by Section 4(a),
            each person who is, or will become, a Non-Employee Director upon the
            consummation of the Company's initial public offering (the "IPO") of
            its Common Shares shall, without further action by the Board,
            automatically receive an Initial Grant determined by dividing
            $_______ (prorated as determined below in this Section 4(b)) by the
            initial price to the public in the IPO; provided, however, that the
            number of shares of Restricted Stock shall be rounded down such that
            no fractional share shall be issued. The Initial Grant to be made
            pursuant to this Section 4(b) shall be prorated for the number of
            whole months that such Non-Employee Director will serve from the
            consummation of the IPO to June 1, 2006.

                                       3
<PAGE>

      (c)         Each Initial Grant shall constitute an immediate transfer of
            the ownership of shares of Restricted Stock to the Non-Employee
            Director, entitling such Non-Employee Director to voting, dividend
            and other ownership rights, but subject to the substantial risk of
            forfeiture and restrictions on transfer set forth in this Section 4.

      (d)         Each Initial Grant shall provide that the shares of Restricted
            Stock covered by such Initial Grant shall be subject to a
            "substantial risk of forfeiture" until the first Annual Meeting
            after the Date of Grant. Each Initial Grant shall provide that the
            Non-Employee Director shall forfeit the shares of Restricted Stock
            covered by such Initial Grant if such Non-Employee Director
            terminates his or her service with the Company while such shares of
            Restricted Stock are subject to a substantial risk of forfeiture.
            Notwithstanding the foregoing, each such Initial Grant shall provide
            for the immediate lapse of such substantial risk of forfeiture in
            the event of (i) the Non-Employee Director's death or Total
            Disability, or (ii) upon a Change in Control.

      (e)         Each Initial Grant shall require that any and all dividends or
            other distributions (other than cash dividends) declared or
            otherwise distributed thereon be subject to the same restrictions as
            the underlying Initial Grant.

      (f)         Each Initial Grant shall provide that during the period for
            which such substantial risk of forfeiture has not lapsed, the shares
            of Restricted Stock shall not be sold or otherwise transferred,
            other than by will or the laws of descent and distribution.

      (g)         Each Initial Grant shall be evidenced by an Award Agreement,
            which shall contain such terms and provisions not inconsistent with
            this Plan as the Board may approve. Unless otherwise directed by the
            Board, all certificates representing shares of Restricted Stock
            shall be held in custody by the Company until all restrictions
            thereon shall have lapsed, together with a stock power or powers
            executed by the Non-Employee Director in whose name such
            certificates are registered, endorsed in blank.

5.          ANNUAL GRANTS

      (a)         Commencing with the Annual Meeting in 2006, each Non-Employee
            Director who is then elected or is continuing as a Non-Employee
            Director shall, without any further action of the Board,
            automatically receive an Annual Grant determined by dividing
            $_______ by the Market Value per Share on the Date of Grant;
            provided, however, that the number of shares of Restricted Stock
            shall be rounded downward such that no fractional share shall be
            issued.

      (b)         Each Annual Grant shall constitute an immediate transfer of
            the ownership of shares of Restricted Stock to the Non-Employee
            Director, entitling such Non-Employee Director to voting, dividend
            and other ownership rights, but subject to

                                       4
<PAGE>

            the substantial risk of forfeiture and restrictions on transfer set
            forth in this Section 5.

      (c)         Each Annual Grant shall provide that the shares of Restricted
            Stock covered by such Annual Grant shall be subject to a
            "substantial risk of forfeiture" until the first Annual Meeting
            after the Date of Grant. Each Annual Grant shall provide that the
            Non-Employee Director shall forfeit the shares of Restricted Stock
            covered by such Annual Grant if such Non-Employee Director
            terminates his or her service with the Company while such shares of
            Restricted Stock are subject to a substantial risk of forfeiture.
            Notwithstanding the foregoing, each such Annual Grant shall provide
            for the immediate lapse of such substantial risk of forfeiture in
            the event of (i) the Non-Employee Director's death or Total
            Disability, or (ii) upon a Change in Control.

      (d)         Each Annual Grant shall provide that during the period for
            which such substantial risk of forfeiture has not lapsed, the shares
            of Restricted Stock shall not be sold or otherwise transferred,
            other than by will or the laws of descent and distribution.

      (e)         Each Annual Grant shall require that any and all dividends or
            other distributions (other than cash dividends) declared or
            otherwise distributed thereon be subject to the same restrictions as
            the underlying Annual Grant.

      (f)         Each Annual Grant shall be evidenced by an Award Agreement,
            which shall contain such terms and provisions not inconsistent with
            this Plan as the Board may approve. Unless otherwise directed by the
            Board, all certificates representing Restricted Stock shall be held
            in custody by the Company until all restrictions thereon shall have
            lapsed, together with a stock power or powers executed by the
            Non-Employee Director in whose name such certificates are
            registered, endorsed in blank.

6.          CHANGE IN CONTROL. For purposes of this Plan, except as may be
      otherwise defined in an Award Agreement, a "Change in Control" shall
      mean the occurrence of any of the following events:

      (a)         the acquisition by any Person of beneficial ownership (within
            the meaning of Rule 13d-3 promulgated under the Exchange Act) of 35%
            or more of the then outstanding Voting Securities of the Company;
            provided, however, that for purposes of this Section 6(a), the
            following acquisitions shall not constitute a Change in Control: (A)
            any acquisition by the Company or a Subsidiary of Voting Securities,
            (B) any acquisition of Voting Securities by any employee benefit
            plan (or related trust) sponsored or maintained by the Company or
            any Subsidiary or (C) any acquisition of Voting Securities by any
            Person pursuant to a Business Combination that complies with clauses
            (A), (B) and (C) of Section 6(c) below;

      (b)         a majority of the Board ceases to be comprised of Incumbent
            Directors;

                                       5
<PAGE>

      (c)         consummation of a reorganization, merger or consolidation, a
            sale or other disposition of all or substantially all of the assets
            of the Company or other transaction (each, a "Business
            Combination"), unless, in each case, immediately following the
            Business Combination, (A) all or substantially all of the
            individuals and entities who were the beneficial owners of Voting
            Securities immediately prior to the Business Combination
            beneficially own, directly or indirectly, more than 50% of the
            combined voting power of the then outstanding Voting Securities of
            the entity resulting from the Business Combination (including,
            without limitation, an entity which as a result of such transaction
            owns the Company or all or substantially all of the Company's assets
            either directly or through one or more subsidiaries), (B) no Person
            (other than the Company, such entity resulting from the Business
            Combination, or any employee benefit plan (or related trust)
            sponsored or maintained by the Company, any Subsidiary or such
            entity resulting from the Business Combination) beneficially owns,
            directly or indirectly, 35% or more of the combined voting power of
            the then outstanding Voting Securities of the entity resulting from
            the Business Combination; provided, however, that no Person will be
            treated for purposes of this Section 6(c) as beneficially owning 35%
            or more of the Voting Securities of the entity resulting from the
            Business Combination solely as a result of the Voting Securities
            held in the Company prior to consummation of the Business
            Combination and (C) at least a majority of the members of the board
            of directors of the entity resulting from the Business Combination
            were Incumbent Directors at the time of the execution of the initial
            agreement or of the action of the Board providing for the Business
            Combination; or

      (d)         approval by the shareholders of the Company of a complete
            liquidation or dissolution of the Company, except pursuant to a
            Business Combination that complies with clauses (A), (B) and (C) of
            Section 6(c) hereof.

      Notwithstanding anything to the contrary contained in this Section 6, a
Person who holds 35% or more of the Voting Securities of the Company on the
Effective Date will not be deemed to have acquired 35% or more of the Voting
Securities of the Company for purposes of Section 6(a) of this Plan (and as a
result, such circumstance shall not constitute a Change in Control) unless after
the Effective Date such person acquires, in one or more transactions, additional
Voting Securities of the Company representing 1% or more of the then outstanding
Voting Securities of the Company it being understood that an increase in the
percentage of Voting Securities held by a Person as a result of the Company's
repurchase of Voting Securities of the Company is not an acquisition of Voting
Securities by such Person.

7.          FRACTIONAL SHARES. The Company shall not issue any fractional
      Common Shares pursuant to this Plan.

8.          ADMINISTRATION OF THE PLAN.

      (a)         This Plan shall be administered by the Board, which may from
            time to time delegate all or any part of its authority under this
            Plan to a committee of the Board (or a subcommittee thereof). To the
            extent of any such delegation,

                                       6
<PAGE>

            references in this Plan to the Board shall be deemed to be
            references to such committee or subcommittee.

      (b)         The interpretation and construction by the Board of any
            provision of this Plan or of any Award Agreement, and any
            determination by the Board pursuant to any provision of this Plan or
            of any such Award Agreement, shall be final and conclusive. No
            member of the Board shall be liable for any such action or
            determination made in good faith.

9.          AMENDMENT AND TERMINATION OF PLAN. The Board may from time to time
      and at any time amend or terminate the Plan in whole or in part; provided,
      however, that any amendment (i) which must be approved by the shareholders
      of the Company in order to comply with applicable law or the rules of the
      principal exchange on which the Common Shares are traded or quoted, or
      (ii) which would increase the benefits accruing to Non-Employee Directors,
      increase the aggregate number of Common Shares that may be issued under
      the Plan or materially modify the eligibility requirements for
      participating in the Plan, shall not be effective unless and until the
      shareholders of the Company have approved such amendment. Notwithstanding
      anything to the contrary set forth in this Plan, following the IPO in the
      event the common stock of the Company is no longer listed for trading with
      a national securities exchange or the Nasdaq National Market System, then
      all future grants under this Plan shall be suspended until the Board shall
      take further action with respect thereto.

10.         GOVERNING LAW. All issues concerning construction, validity and
      interpretation of this Plan and all Awards granted hereunder shall be
      governed by the law of the State of Texas, without regard to such state's
      conflict of laws rules.

11.         GENERAL PROVISIONS.

      (a)         Nothing in the Plan shall be deemed to create any obligation
            on the part of the Board to nominate any Director for reelection by
            the Company's shareholders or to limit the rights of the
            shareholders to remove any Director.

      (b)         All notices under this Plan shall be in writing, and if to the
            Company, shall be delivered to the Secretary of the Company or
            mailed to its principal executive office addressed to the attention
            of the Secretary; and if to a Non-Employee Director, shall be
            delivered personally or mailed to the Non-Employee Director at the
            address appearing on the records of the Company. Such addresses may
            be changed at any time by written notice to the other party.

                                       7<PAGE>
                                                                   Exhibit 10.16

                               SERVICES AGREEMENT

This Services Agreement ("Agreement") is made and entered into effective the 31M
day of March, 2005 (the ("Effective Date"), by and between Concentra Integrated
Services, Inc. ("CIS") and Amerisafe Risk Services, Inc. ("ARS").

     WHEREAS, CIS offer workers' compensation payors a variety of health care
management and cost containment services;

     WHEREAS, ARS is a health care payor that requires certain health care
management and cost containment services; and

     WHEREAS, ARS desires to engage CIS to perform certain health care
management and/or cost containment services upon its request and CIS desires to
provide such services, pursuant to and in accordance with the terms of this
Agreement;

     NOW, THEREFORE, in consideration of the foregoing premises, and the mutual
covenants conditions contained herein, the parties agree as follows:

1.   SERVICES

          1.1 DESCRIPTION OF SERVICES. ARS hereby engages CIS, by itself and
     through its affiliated organizations including Concentra Preferred Systems,
     Inc. ("CPS"), to perform the specific health care management and/or cost
     containment services (collectively, the "Services") described on Exhibit A.

          1.2 REPORTS. CIS hereby agrees to provide ARS with monthly and/or
     quarterly reports that ARS and CIS mutually agree upon, which summarize and
     describe the Services that were provided to ARS by CIS for the previous
     period. If ARS requests additional reports, CIS will make commercially
     reasonable efforts to provide the reports requested by ARS in a format that
     ARS and CIS mutually agreed upon.

2.   FINANCIAL MATTERS.

          2.1 COMPENSATION. ARS will pay CIS for the performance of Services in
     accordance with Exhibit A CIS will provide invoices to ARS each month that
     itemizes the Services provided by CIS for ARS. ARS will notify CIS of any
     disputed amounts within 15 days of the date ARS receives the invoice. ARS
     will pay each undisputed invoice within thirty (30) days of receipt. Any
     payment of undisputed amounts that is not made by ARS within thirty (30)
     days of receipt of CIS' invoice will bear interest at the rate of one and
     one-half percent (1.5%) per month or, if lesser, the maximum rate permitted
     by applicable law.

          2.2 RESPONSIBILITY FOR BILL PAYMENT. Both parties acknowledge and
     agree that the adjudication and payment of benefits for health care
     services is solely ARS's right and its responsibility and that CIS has no
     authority or responsibility for such payment Both parties agree not to make
     any representation to the contrary to any person.
<PAGE>
3.   INSURANCE. CIS will procure and maintain at CIS' sole cost and expense all
     insurance coverage required by applicable law and by customary business
     practices for the performance of the Services. At a minimum, such coverage
     will include:

               (a)  workers' compensation insurance at statutory limits;

               (b)  general liability insurance with limits of not less than $1
                    million per claim and $3 million in the aggregate, and

               (c)  professional liability insurance with limits of not less
                    than $1 million per medical incident and $3 million in the
                    aggregate.

     Upon receipt of its written request, CIS will provide a certificate of
     insurance evidencing the foregoing coverage.

4.   COMPLIANCE WITH GOVERNMENTAL REQUIREMENTS. In performing their respective
     obligations under this Agreement and the activities contemplated hereby,
     each party and its respective officers, directors, employees, agents,
     subcontractors, and independent contractors will comply fully with all
     applicable laws, rules and regulations.

5.   TERM AND TERMINATION.

          5.1 The term of this Agreement will be one (1) year commencing on the
     Effective Date. This Agreement will automatically renew for successive one
     (1) year terms, subject to earlier termination by either of the parties as
     the terms of this Agreement provide.

          5.2 This Agreement, and all rights and duties hereunder, will
     terminate if any of the following events occur:

               (a)  The parties mutually agree to terminate this Agreement in
                    writing;

               (b)  One of the parties provides the other, at anytime, without
                    cause, sixty (60) days prior written notice of its intention
                    to terminate this Agreement;

               (c)  Upon notice if a government body with regulatory authority
                    over either of the parties' activities notifies ARS that it
                    no longer approves its use of CIS' Services or there is a
                    change in an applicable state or federal law or regulation,
                    or an administrative or judicial order or decision
                    significantly reduces or prevents either of the parties from
                    fulfilling CIS' obligations under this Agreement; or

               (d)  Either of the parties materially breaches or defaults in its
                    performance under this Agreement, and fails to cure or
                    commence to cure such breach or default to the other's
                    satisfaction within thirty (30) days after receipt of
                    written notice of such breach or default. Failure to obtain
                    and maintain any required licenses, certifications or
                    accreditations necessary to conduct business under this
                    Agreement will be considered to be a material default;
<PAGE>
               (e)  In the event ARS and MedRisk, Inc. ("MedRisk") terminate
                    their relationship, this contract will be renegotiated
                    within 30 days after the data CIS is notified in writing by
                    ARS of said termination In the event of such termination,
                    ARS will notify CIS within five (5) business days.

          5.3 Sections 5, 6, 7, 8, 9, 11 and 12 will survive the termination of
     this Agreement.

6.   WORK PRODUCT.

          6.1 For the purposes of this Agreement, "Work Product" is defined as
     all inventions, improvements, computer programs, discoveries, ideas,
     processes, systems, writings, or other works made or conceived by CIS, CIS'
     employees, agents, or independent contractors which are (a)(i) produced
     directly in the course of performing the Services under this Agreement but
     that are outside the normal scope of such performance; or (ii) developed or
     made during the term of this Agreement with the use of any of its
     proprietary systems; and (b) are directly related to a specific service or
     product development ARS requests; and (c) are unique to ARS and not
     developed for use generally with CIS' other clients. CIS hereby assigns to
     ARS all rights, title and interest it may have in the Work Product at all
     stages of development and upon completion, and all patents and copyrights
     in the Work Product. CIS will render all reasonably required assistance to
     ARS to protect the rights described above.

          6.2 CIS has not and will not assign, license or otherwise transfer
     ownership, rights, title, or interest in the Work Product to any third
     party.

          6.3 The parties agree that Work Product does not include any
     inventions, improvements, computer programs, discoveries, ideas, processes,
     systems, writings, or other works (a) that existed prior to the Effective
     Date, or (b) that CIS, or any third party CIS has hired, developed,
     conceived or existed prior to the Effective Date, or (c) that CIS, or any
     third party CIS has hired, independently develop without its dedicated
     financial assistance after the Effective Date.

7.   OWNERSHIP OF INFORMATION AND DATA REQUIREMENTS

          7.1 All ARS specific information, data, documents, records, reports
     will at all times be considered its property. CIS may, however, retain
     copies of any documents, including but not limited to the Work Product,
     that might be necessary to defend any suit relating to CIS' Services under
     this Agreement or in the normal course of CIS' business.

          7.2 AI data analysis and evaluation tools, including information
     systems, technology, report formats, computer programs, processes, efforts
     and methods developed or used by CIS in performing this Agreement will
     remain CIS' sole property.

          7.3 If this Agreement is terminated, CIS will provide ARS or its
     successor with those records reasonably required for subsequent
     administration in the standard format then used by CIS for storage of
     records subject to applicable laws. ARS and/or
<PAGE>
     such successor provider will make records serviced by CIS reasonably
     available to CIS for litigation, pre-litigation and for conflict resolution
     purposes.

8.   CONFIDENTIALITY.

          8.1 "Confidential Information" means all written and oral information,
     documents and data previously or hereafter obtained by one of CIS or CIS'
     representatives from the other, or its affiliates or representatives, in
     connection with this Agreement and the transactions it contemplates, and
     includes proprietary services and methodologies, negotiated contract rates,
     technical data, programs, customer lists, lists of employees and agents,
     sales and marketing plans, operating procedures, agreements and related
     information, the past, present, and prospective methods, procedures, and
     techniques utilized in identifying prospective referral sources,
     compilations of information, records, and processes which are used in the
     operation of CIS' respective businesses, and all confidential medical
     information.

          8.2 Each of the parties acknowledges that the other's Confidential
     Information constitutes valuable property and trade secrets, which are
     entitled to protection. Each of the parties will hold all Confidential
     Information in strict confidence, and neither of the parties nor any of
     CIS' affiliates or representatives will directly or indirectly (a) use or
     permit the use of any of the other's Confidential Information for or in
     connection with any purpose other than the performance of this Agreement
     (b) disclose or permit the disclosure of any of the other's Confidential
     Information to any person or entity other than the other's representatives,
     or (c) duplicate, copy or reproduce any of the Confidential information
     except with the prior consent of the owner, except as necessary for the
     performance of this Agreement or for review by CIS' respective officers or
     shareholders or their representatives However, the obligation o hold
     Confidential Information in confidence and not to use, copy or disclose it
     will not extend to the following information that may otherwise constitute
     Confidential Information:

                    (i)  Information that, at the time of the use, copying or
                         disclosure, was readily ascertainable from public
                         sources or was known by or available to competitors,
                         clients or customers of either of the parties by
                         publication or otherwise, sources which arise by virtue
                         of this Agreement;

                    (ii) Information that comes from a third party and was not
                         acquired by such third party in violation of any
                         obligation of confidentiality;

                    (iii) Information required to be disclosed by law, provided
                         that disclosure of such information will be limited to
                         only such disclosure that is required to be made by
                         applicable law;

                    (iv) Information that has been used for statistical purposes
                         only, with all identifying information as to its origin
                         or source removed; or
<PAGE>
                    (v)  Information that the parties have agreed to share to
                         advance joint projects between Concentra and ARS.

     Without limiting any other obligations or liability of either of the
     parties under this Agreement, each of the parties will take an appropriate
     and reasonable action necessary to prevent the unauthorized use,
     disclosure, copying or reproduction and to protect and maintain the
     confidentiality of the Confidential Information. Each of the parties will
     advise its respective representatives of the terms of this Section and use
     reasonable efforts to cause them to comply with its terms. Each of the
     parties will immediately notify the other of the circumstances surrounding
     any breach of this Section.

          8.3 Within ten (10) days after receiving written request from the
     owner of Confidential Information to return Confidential Information, all
     documents and other materials constituting such Confidential Information,
     including all copies, reproductions, extracts, and summaries of such
     Confidential Information will be returned to its owner except what may be
     necessary to continue to perform the Services.. Any portion of the
     Confidential information that consists of analysis, computations, studies
     or notes prepared by the receiving party or its representatives, or is
     necessary to continue performing the Services will be either held by the
     recipient or its representatives and kept confidential subject to the terms
     of this Agreement, or destroyed.

          8.4 Both parties acknowledge that the breach or attempted breach of
     obligations under this Section will cause irreparable injury and that any
     remedy at law will be inadequate. Both parties acknowledge that, in
     addition to any other relief, each of the parties will be entitled to seek
     injunctive and other equitable relief in case of any such breach or
     attempted breach. Both parties expressly waive any requirement that the
     breaching party could assert for the securing or posting of any bond in
     connection with the obtaining of such injunctive or other equitable relief.

          8.5 Each of the parties will comply with any applicable federal or
     state laws or regulations that are or may become effective during the term
     of this Agreement.

9.   INDEPENDENT CONTRACTOR.

          9.1 Each of the parties is an independent contractor of the other and
     neither of the parties is a partner, joint venturer, agent or
     representative of the other. There is no employment relationship between
     them. Neither of the parties has the right or authority to make any
     representation or warranty or incur any obligation or liability on behalf
     of the other. Neither of the parties will make any representation to a
     third party inconsistent with this paragraph. ARS will have no control over
     the employment, discharge, compensation of and service rendered by CIS'
     employees or agents.

          9.2 CIS reserves the right to outsource, at CIS' sole discretion, some
     or all of the Services it is required to perform under this Agreement to
     subcontractors of CIS' choice CIS will notify ARS 30 days in advance of any
     additions or deletions of PPO networks available to ARS that have been
     mutually agreed upon.
<PAGE>
10.  INDEMNIFICATION.

          10.1 Each of the parties hereby covenants and agrees to indemnify,
     defend, and hold harmless the other, and its officers, directors,
     employees, and affiliates, from and against any and all liability, loss,
     cost, or expense (including, without limitation, reasonable attorneys'
     fees), arising out of its own material breach, negligence or misconduct in
     the performance of its respective duties and obligations in this Agreement
     and for any claim by a third party of violation of its intellectual
     property rights.

          10.2 Written notice will be promptly provided to the indemnifier of
     any claim that is being asserted for which such indemnification is sought
     That notice will include a true copy of the claim including, and any
     summons or other process, pleading, or notice issued in any lawsuit or
     other proceeding to assert or enforce such claim If the receiver of the
     notice accepts the obligation to indemnify, the receiver reserves the right
     to control the investigation, trial, and defense of such lawsuit or action
     (including all negotiations to effect settlement) and any appeal arising
     there from and to employ or engage attorneys of its own choice.

          10.3 The party who is seeking indemnification, may, at its own cost,
     participate in such investigation, trial, and defense of such lawsuit or
     action and any appeal arising there from. Each of the parties' respective
     employees, agents, servants, and representatives will provide full
     cooperation to the other at all times during the pendency of the claim or
     lawsuit, including without limitation, and all available information with
     respect thereto.

11.  AUDIT

          11.1 CIS will maintain records applicable to the work performed under
     this Agreement. CIS will keep these records available for inspection by
     ARS, its auditors and advisors as provided under applicable laws for a
     period of three (3) years following completion of work or expiration or
     termination of this Agreement.

          11.2 At any time during the three (3) year period but no more
     frequently than twice annually, during which the records are maintained by
     CIS, ARS may audit those of CIS' records that are directly related to this
     Agreement to determine the accuracy of bills submitted by CIS under the
     compensation section hereto. ARS must give CIS at least ten (10) days prior
     written notice of its intention to perform an audit.

12.  DISPUTE RESOLUTION,

          12.1 The parties will work together in good faith to resolve any
     disputes about their business relationship In case of any dispute arising
     between the parties to this Agreement that the parties cannot resolve
     themselves after a good faith attempt, the parties agree to binding
     arbitration to resolve any such dispute. Either party may initiate such
     binding arbitration to take place at a mutually agreeable location by
     notifying the other party in writing. Each party will bear the expense of
     its own arbitrator and attorney's fees and both parties will share equally
     the expense of the arbitrators and the arbitration. Arbitrators will have
     no authority to award punitive or exemplary damages. In addition, their
     parties expressly waive and disclaim any right to bring any claim in any
<PAGE>
     and all forums as a class action or as a private Attorney General. No party
     may serve as a class representative or a member of a class in litigation
     adverse to another party.

13.  MISCELLANEOUS PROVISIONS.

          13.1 This Agreement (including the recitals and all exhibits attached
     hereto) (i) represents the entire agreement between the parties with
     respect to the subject matter of this Agreement (ii) supersedes all prior
     and contemporaneous purchase orders, agreements, understandings,
     representations and warranties relating to the subject matter of this
     Agreement, and (iii) may only be amended, canceled or rescinded by a
     writing signed by both of parties.

          13.2 All notices and consents permitted or required under this
     Agreement must be in writing and will be deemed received upon to the
     address set forth below either in person or by commercial courier with
     confirmation of receipt or three (3) days after submission by registered or
     certified mail:

          CIS:  Concentra Integrated Services, Inc.
                5080 Spectrum Drive, Suite 400 West
                Addison, Texas 75001
                Fax: (972) 387-1938
                Attention: Office of General Counsel

          ARS:  Amerisafe Risk Services, Inc.
                2301 Highway 190 West
                DeRidder, Louisiana 70634
                Attention: H.O. "Chris" Lestage, IV

          13.3 Section and other headings in this Agreement are for convenience
     only and will not be used to affect, broaden or limit this Agreement.

          13.4 This Agreement will be governed and enforced in accordance with
     the laws of the State of Texas, without regard to conflict of law
     provisions.

          13.5 If any provision in this Agreement is determined by a court of
     competent jurisdiction to be invalid or unenforceable, such provision will
     be construed, limited or, severed, but only to the extent necessary to
     eliminate such invalidity or unenforceability, and the other provisions of
     this Agreement will remain unaffected.

          13.6 This Agreement represents the wording selected mutually by the
     parties to define this Agreement and no rule of strict construction will
     apply against either of the parties. Whenever the context reasonably
     permits, the singular will include the plural, the plural will include the
     singular, and the whole will include any part thereof.

          13.7 This Agreement will be binding upon and inure to the benefit of
     each of the parties and their respective representatives, successors and
     permitted assigns.

          13.8 Except for obligations to make payment, neither of the parties
     will be liable to the other for any failure of (or delay in performance of)
     its respective obligations hereunder due to any cause or circumstance which
     is beyond its reasonable control
<PAGE>
     including, but without limiting the generality of the foregoing, any
     failure or delay caused by strike, lockout, labor shortage, fire,
     explosion, shipwreck, act of God or the public enemy, war, riot,
     interference by the military or governmental authorities, or compliance
     with the laws of the United States or with the laws or orders of any other
     government or regulatory authority.

          13.9 This Agreement may be executed in any number of duplicate
     counterparts, each of which will be deemed an original, but all of which
     taken together will constitute one and the same instrument.

          13.10 Except as provided for herein, neither of the parties may
     modify, publish, transfer or assign any material in any media provided by
     the other, in whole or part or without the other's express written
     permission, nor may either of the parties use the other's name, trademark
     or other proprietary material without the other's written permission.
     Neither of the parties will use the other's trademarks, trade names or
     logos without the prior written permission of the owner of the marks.

          13.11 This Agreement or any duty or obligation of performance
     hereunder may not be assigned, in whole or in part, by either of the
     parties without the prior written consent of the other, except that either
     of the parties may assign this Agreement to its parent or any subsidiary or
     in the event of a sale or merger of the majority of its assets without the
     other's prior consent.

          13.12 Acceptance by either of the parties of any performance less than
     required hereby will not be deemed to be a waiver or the right to enforce
     all of the terms and conditions of this Agreement. No waiver of any such
     right will be binding unless either of the parties puts such waiver in
     writing and it is signed by both of the parties.

     IN WITNESS WHEREOF, the parties hereto have executed this Agreement in
duplicate as of the date first herein written.

Concentra Integrated Services, Inc.:     Amerisafe Risk Services, Inc.:

By: /s/ Bruce D. Singleton               By: /s/ H.O. Lestage, IV
    ----------------------------------       -----------------------------------
Name: Bruce D. Singleton                 Name: H.O. "Chris" Lestage, IV
Title: Vice President                    Title: Senior Vice President, Claims

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00090-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00090-of-00352.parquet"}]]